{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:43:48Z","timestamp":1792205028130,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.cca.2023.117302","type":"journal-article","created":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T19:17:47Z","timestamp":1679339867000},"page":"117302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Identification of a novel plasma metabolite panel as diagnostic biomarker for hepatocellular carcinoma"],"prefix":"10.1016","volume":"543","author":[{"given":"Zhiying","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cca.2023.117302_b0005","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.cca.2023.117302_b0010","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.7150\/ijbs.69526","article-title":"Enhanced pentose phosphate pathway activity promotes pancreatic ductal adenocarcinoma progression via activating YAP\/MMP1 axis under chronic acidosis","volume":"18","author":"Chen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2023.117302_b0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Can. Cell"},{"key":"10.1016\/j.cca.2023.117302_b0020","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/erm.2019.4","article-title":"Warburg and Krebs and related effects in cancer","volume":"21","author":"Unterlass","year":"2019","journal-title":"Expert Rev. Mol. Med."},{"issue":"30","key":"10.1016\/j.cca.2023.117302_b0025","doi-asserted-by":"crossref","first-page":"47332","DOI":"10.18632\/oncotarget.10119","article-title":"Plasma metabolomic analysis of human hepatocellular carcinoma: diagnostic and therapeutic study","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.cca.2023.117302_b0030","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jhep.2022.04.038","article-title":"Metabolic reprogramming in cholangiocarcinoma","volume":"77","author":"Raggi","year":"2022","journal-title":"J. Hepatol."},{"issue":"6487","key":"10.1016\/j.cca.2023.117302_b0035","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cca.2023.117302_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.875324","article-title":"Hepatocyte-specific knock-out of Nfib aggravates hepatocellular tumorigenesis via enhancing urea cycle","volume":"9","author":"Zhou","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"1","key":"10.1016\/j.cca.2023.117302_b0045","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41467-023-36708-5","article-title":"PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.cca.2023.117302_b0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/cr.2015.33","article-title":"cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions","volume":"25","author":"Sun","year":"2015","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.cca.2023.117302_b0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ijc.33236","article-title":"Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study","volume":"148","author":"Stepien","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.cca.2023.117302_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112648","article-title":"Association between pre-diagnostic serum bile acids and hepatocellular carcinoma: the singapore chinese health study","volume":"13","author":"Thomas","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2023.117302_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103661","article-title":"The altered serum lipidome and its diagnostic potential for non-alcoholic fatty liver (NAFL)-associated hepatocellular carcinoma","volume":"73","author":"Lewinska","year":"2021","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.cca.2023.117302_b0070","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.cca.2023.117302_b0075","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.18632\/aging.102907","article-title":"LncRNA-LALR1 upregulates small nucleolar RNA SNORD72 to promote growth and invasion of hepatocellular carcinoma","volume":"12","author":"Mao","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.cca.2023.117302_b0080","article-title":"Transcriptional regulation of NDUFA4L2 by NFIB induces sorafenib resistance by decreasing reactive oxygen species in hepatocellular carcinoma","author":"Zhou","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cca.2023.117302_b0085","article-title":"New advances in the diagnosis and management of hepatocellular carcinoma","volume":"371","author":"Yang","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.cca.2023.117302_b0090","doi-asserted-by":"crossref","first-page":"5087643","DOI":"10.1155\/2020\/5087643","article-title":"Evaluation of the combined application of AFP, AFP-L3%, and DCP for hepatocellular carcinoma diagnosis: a meta-analysis","volume":"2020","author":"Wang","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.cca.2023.117302_b0095","unstructured":"e.e.e. European Association for the Study of the Liver. Electronic address, L. European Association for the Study of the, EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma, J Hepatol 69(1) (2018) 182-236."},{"key":"10.1016\/j.cca.2023.117302_b0100","doi-asserted-by":"crossref","first-page":"1065506","DOI":"10.3389\/fmedt.2022.1065506","article-title":"Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine","volume":"4","author":"Wu","year":"2022","journal-title":"Front. Med. Technol."},{"issue":"10","key":"10.1016\/j.cca.2023.117302_b0105","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1002\/ijc.33051","article-title":"Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies","volume":"147","author":"Petrick","year":"2020","journal-title":"Int. J. Can."},{"issue":"3","key":"10.1016\/j.cca.2023.117302_b0110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/mas.21439","article-title":"Advanced mass spectrometry-based multi-omics technologies for exploring the pathogenesis of hepatocellular carcinoma","volume":"35","author":"Nie","year":"2016","journal-title":"Mass Spectrom. Rev."},{"issue":"7216","key":"10.1016\/j.cca.2023.117302_b0115","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Systems biology: metabonomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.cca.2023.117302_b0120","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/s41592-021-01197-1","article-title":"Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices","volume":"18","author":"Alseekh","year":"2021","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.cca.2023.117302_b0125","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.cca.2023.117302_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/nu13082794","article-title":"Citrulline, biomarker of enterocyte functional mass and dietary supplement. metabolism, transport, and current evidence for clinical use","volume":"13","author":"Maric","year":"2021","journal-title":"Nutrients"},{"issue":"18","key":"10.1016\/j.cca.2023.117302_b0135","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1158\/0008-5472.CAN-21-3914","article-title":"GLS2 is a tumor suppressor and a regulator of ferroptosis in hepatocellular carcinoma","volume":"82","author":"Suzuki","year":"2022","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cca.2023.117302_b0140","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1002\/hep.32062","article-title":"IL-1beta-induced elevation of solute carrier family 7 member 11 promotes hepatocellular carcinoma metastasis through up-regulating programmed death ligand 1 and colony-stimulating factor 1","volume":"74","author":"He","year":"2021","journal-title":"Hepatology"},{"issue":"7516","key":"10.1016\/j.cca.2023.117302_b0145","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature13441","article-title":"Mutant IDH inhibits HNF-4\u03b1 to block hepatocyte differentiation and promote biliary cancer","volume":"513","author":"Saha","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.cca.2023.117302_b0150","first-page":"345","article-title":"alpha-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer","volume":"1","author":"Tran","year":"2020","journal-title":"Nat. Can."},{"key":"10.1016\/j.cca.2023.117302_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112394","article-title":"Alpha-ketoglutarate decorated iron oxide-gold core-shell nanoparticles for active mitochondrial targeting and radiosensitization enhancement in hepatocellular carcinoma","volume":"129","author":"Sood","year":"2021","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"issue":"1","key":"10.1016\/j.cca.2023.117302_b0160","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.molcel.2019.07.007","article-title":"Alpha-ketoglutarate-activated NF-kappaB signaling promotes compensatory glucose uptake and brain tumor development","volume":"76","author":"Wang","year":"2019","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.cca.2023.117302_b0165","doi-asserted-by":"crossref","first-page":"M110","DOI":"10.1074\/mcp.M110.004945","article-title":"Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma","volume":"10","author":"Chen","year":"2011","journal-title":"Mol. Cell. Proteomics"},{"issue":"1","key":"10.1016\/j.cca.2023.117302_b0170","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1038\/s41598-018-21595-4","article-title":"Small molecule metabolite biomarkers for hepatocellular carcinoma with bile duct tumor thrombus diagnosis","volume":"8","author":"Tan","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cca.2023.117302_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081086","article-title":"Altered L-arginine metabolic pathways in gastric cancer: potential therapeutic targets and biomarkers","volume":"11","author":"Bednarz-Misa","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.cca.2023.117302_b0180","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s40425-019-0658-1","article-title":"Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab","volume":"7","author":"Ouaknine Krief","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2023.117302_b0185","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1038\/s41467-021-22235-8","article-title":"Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor","volume":"12","author":"Zou","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2023.117302_b0190","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3389\/fonc.2018.00552","article-title":"Identification and functional characterization of anti-metastasis and anti-angiogenic activities of triethylene glycol derivatives","volume":"8","author":"Oh","year":"2018","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.cca.2023.117302_b0195","doi-asserted-by":"crossref","first-page":"97008","DOI":"10.1289\/EHP4713","article-title":"Generating the blood exposome database using a comprehensive text mining and database fusion approach","volume":"127","author":"Barupal","year":"2019","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cca.2023.117302_b0200","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.copbio.2015.08.022","article-title":"Top value platform chemicals: bio-based production of organic acids","volume":"36","author":"Becker","year":"2015","journal-title":"Curr. Opin. Biotechnol."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123001043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898123001043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:07:36Z","timestamp":1757862456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898123001043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":40,"alternative-id":["S0009898123001043"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2023.117302","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a novel plasma metabolite panel as diagnostic biomarker for hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2023.117302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117302"}}